Clinical trial
Evaluation of the Efficacy and Safety of Dallixa® Eyelash Serum (Produced by Quantum Aesthetics Cosmetics, Turkey) in Subjects With Idiopathic Eyelash Hypotrichosis
NCT07776028 is registered in ClinicalTrials.gov with Quantum Aesthetics Cosmetics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of Dallixa® Eyelash Serum (Produced by Quantum Aesthetics Cosmetics, Turkey) in Subjects With Idiopathic Eyelash Hypotrichosis
- Lead sponsor
- Quantum Aesthetics Cosmetics
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 28, 2025
- Completion date
- February 17, 2026
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.